119 related articles for article (PubMed ID: 35388441)
1. [High clinical value of bone scintigraphy as a staging method for breast cancer].
Eilsberger F; Girmond C; Boekhoff J; Librizzi D; Luster M; Pfestroff A
Nuklearmedizin; 2022 Aug; 61(4):308-313. PubMed ID: 35388441
[TBL] [Abstract][Full Text] [Related]
2. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.
Yilmaz MH; Ozguroglu M; Mert D; Turna H; Demir G; Adaletli I; Ulus S; Halac M; Kanberoğlu K
Med Oncol; 2008; 25(3):257-63. PubMed ID: 18040900
[TBL] [Abstract][Full Text] [Related]
4. [Bone scintigraphy for the staging of lymphogranulomatosis?].
Hundeshagen H; Diehl V; Creutzig H
Strahlentherapie; 1985 Aug; 161(8):502-5. PubMed ID: 4024169
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.
Engelhard K; Hollenbach HP; Wohlfart K; von Imhoff E; Fellner FA
Eur Radiol; 2004 Jan; 14(1):99-105. PubMed ID: 12845463
[TBL] [Abstract][Full Text] [Related]
6. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
[TBL] [Abstract][Full Text] [Related]
7. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
[TBL] [Abstract][Full Text] [Related]
8. [Value of skeletal scintigraphy in the follow-up of breast cancer].
Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
[TBL] [Abstract][Full Text] [Related]
9. [Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].
Dose-Schwarz J; Mahner S; Schirrmacher S; Jenicke L; Müller V; Habermann CR; Brenner W
Nuklearmedizin; 2008; 47(3):97-103. PubMed ID: 18493688
[TBL] [Abstract][Full Text] [Related]
10. Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer.
Furrer MA; Grueter T; Bosshard P; Vartolomei MD; Kiss B; Thalmann GN; Roth B
Eur Urol Focus; 2021 Sep; 7(5):1052-1060. PubMed ID: 33060038
[TBL] [Abstract][Full Text] [Related]
11. Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient.
Groves AM; Beadsmoore CJ; Cheow HK; Balan KK; Courtney HM; Kaptoge S; Win T; Harish S; Bearcroft PW; Dixon AK
Eur Radiol; 2006 May; 16(5):1066-73. PubMed ID: 16402253
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
Nicolini A; Ferrari P; Sagripanti A; Carpi A
Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
[TBL] [Abstract][Full Text] [Related]
13. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
[TBL] [Abstract][Full Text] [Related]
14. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.
Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C
Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172
[TBL] [Abstract][Full Text] [Related]
15. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
Anger K; Möller T; Zeimantz E
Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
[TBL] [Abstract][Full Text] [Related]
16. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.
Crippa F; Bombardieri E; Seregni E; Castellani MR; Gasparini M; Maffioli L; Pizzichetta M; Buraggi GL
J Nucl Biol Med (1991); 1992; 36(1):52-5. PubMed ID: 1450226
[TBL] [Abstract][Full Text] [Related]
19. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Botsikas D; Bagetakos I; Picarra M; Da Cunha Afonso Barisits AC; Boudabbous S; Montet X; Lam GT; Mainta I; Kalovidouri A; Becker M
Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
[TBL] [Abstract][Full Text] [Related]
20. [Is preoperative bone scintigraphy in early stage of breast cancer T1N0 indicated and meaningful?].
Žaloudík J; Skovajsová M; Česlarová K; Bieberová L; Hussarová L; Zimovjanová M; Petruželka L
Klin Onkol; 2013; 26(6):443-7. PubMed ID: 24320594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
